CurrentRheuma
Get Weekly

CurrentRheuma coverage · page 4 of 48

Rheumatology (Oxford)

Briefs 121–160 of 1,905 CurrentRheuma has covered from this journal, newest publication first

Latest from Rheumatology (Oxford)

All coverage, newest first

  1. Rheumatology (Oxford)

    Annual gout flare frequency as a marker of sustained cardiovascular risk: a clinical threshold for risk stratification

    Cohort studyGout & crystals

  2. Rheumatology (Oxford)

    Effectiveness and probability of full disease control with canakinumab in familial Mediterranean fever: real-world data from the AIDA Network

    Cohort studyAutoinflammatory & rare

  3. Rheumatology (Oxford)

    Free IL-18 in NLRC4-associated autoinflammatory disease without macrophage activation syndrome

    Mechanistic studyAutoinflammatory & rare

  4. Rheumatology (Oxford)

    Systemic juvenile idiopathic arthritis: Are there any predictors of disease course?

    Cohort studyPediatric

  5. Rheumatology (Oxford)

    Assessing the mortality burden after acute myocardial infarction in SLE: insights from the MINAP Registry

    Cohort studyLupus & APS

  6. Rheumatology (Oxford)

    Disparities in severe infection risk associated with SLE: evidence from a causal forest analysis

    Cohort studyLupus & APS

  7. Rheumatology (Oxford)

    Examining the role of dipeptidyl peptidase IV (DPPIV) in psoriatic disease

    Cross-sectional studySpondyloarthritis & PsA

  8. Rheumatology (Oxford)

    Methylation and polygenic risk scores capture different features of Systemic Lupus Erythematosus

    Cross-sectional studyLupus & APS

  9. Rheumatology (Oxford)

    Automated high-resolution CT analysis outperforms visual assessment in predicting interstitial lung disease progression in SSc

    Cohort studySystemic sclerosis

  10. Rheumatology (Oxford)

    Impact of systemic autoimmune diseases in maternal, fetal and neonatal outcomes in Spain

    Cohort studyLupus & APS

  11. Rheumatology (Oxford)

    Paediatric macrophage activation syndrome: clinical features and outcomes across diverse aetiologies

    Cohort studyPediatric

  12. Rheumatology (Oxford)

    The prevalence and incidence of Raynaud’s in England, United Kingdom

    Cohort studySystemic sclerosis

  13. Rheumatology (Oxford)

    A Delphi survey of patients and clinicians on a unified and stratified approach to managing GCA–PMR spectrum disease

    Guideline or statementVasculitis & PMR

  14. Rheumatology (Oxford)

    Vaccination coverage of influenza and pneumococcal vaccines in patients with rheumatic diseases: a systematic review and meta-analysis

    Meta-analysisAcross diseases

  15. Rheumatology (Oxford)

    Cardiac involvement in Behçet’s syndrome: findings from a clinically driven cardiological evaluation

    Cohort studyVasculitis & PMR

  16. Rheumatology (Oxford)

    Clinical and autoantibody associations with malignancy in systemic sclerosis: a systematic review and meta-analysis

    Meta-analysisSystemic sclerosis

  17. Rheumatology (Oxford)

    Development and validation of a relapsing polychondritis disease-specific quality of life instrument (ERN ReCONNET RP-QoL)

    Diagnostic or prognostic studyAutoinflammatory & rare

  18. Rheumatology (Oxford)

    Disease activity and anti-topoisomerase I antibody positivity are associated with elevated serum B cell activating factor levels and a B cell subset-wide reduction of BAFF-receptor expression in SSc

    Cross-sectional studySystemic sclerosis

  19. Rheumatology (Oxford)

    Personalized, physiotherapist-guided exercise programs in JIA: home-based vs. immersive virtual reality (JiaFitXR)

    Randomized controlled trialPediatric

  20. Rheumatology (Oxford)

    Progression from oligoarticular to polyarticular psoriatic arthritis and apremilast as a disease modifier: Novel insights from FOREMOST

    Secondary analysisSpondyloarthritis & PsA

  21. Rheumatology (Oxford)

    Radiographic sacroiliitis progression in psoriatic arthritis

    Cohort studySpondyloarthritis & PsA

  22. Rheumatology (Oxford)

    Stability and prognostic value of B-cell markers in primary SS: results from the French ASSESS cohort

    Cohort studySjögren's & overlap

  23. Rheumatology (Oxford)

    Use of advanced cardiovascular imaging in rheumatic immune-mediated inflammatory diseases

    Cohort studyAcross diseases

  24. Rheumatology (Oxford)

    Prognostic value of quantifying vascular inflammation through ultrasound in patients with giant cell arteritis: the MAGiCUS study

    Cohort studyVasculitis & PMR

  25. Rheumatology (Oxford)

    Detectable safety gestalt of rheumatoid arthritis treatments from pivotal clinical drug trials

    Meta-analysisRA

  26. Rheumatology (Oxford)

    Changing incidence and serotype trends in ANCA-associated vasculitis: a 30-year population-based study in Norfolk, UK

    Cohort studyVasculitis & PMR

  27. Rheumatology (Oxford)

    Loneliness, traditional risk factor control, genetic predisposition, and development of musculoskeletal disorders

    Cohort studyAcross diseases

  28. Rheumatology (Oxford)

    Referral, treatment patterns and change in quality of life in the first 12 months in children and young people with juvenile idiopathic arthritis: an analysis of the association with ethnicity and socioeconomic position using data from a cohort study

    Cohort studyPediatric

  29. Rheumatology (Oxford)

    Standardization of minor salivary gland biopsy interpretation in Sjögren’s disease using the 2017 EULAR recommendations: a monocentric study

    Research articleSjögren's & overlap

  30. Rheumatology (Oxford)

    Targeting LRRC15-expressing fibroblasts holds therapeutic potential to ameliorate inflammation and fibrosis in autoimmune diseases

    Mechanistic studyRA

  31. Rheumatology (Oxford)

    Impact of smoking status on Sjögren’s disease diagnosis and phenotype: results from a cohort study with matched population controls

    Cohort studySjögren's & overlap

  32. Rheumatology (Oxford)

    CAR-T as a salvage treatment in polyrefractory RA

    Cohort studyRA

  33. Rheumatology (Oxford)

    The 2026 British Society for Rheumatology guideline for the management of children, young people and adults with systemic lupus erythematosus

    Guideline or statementLupus & APS

  34. Rheumatology (Oxford)

    Persistence and effectiveness of upadacitinib and TNFi for rheumatoid arthritis using pooled data from Canadian and Swiss registries

    Cohort studyRA

  35. Rheumatology (Oxford)

    Predictors of rapidly progressive interstitial lung disease in anti-MDA5 dermatomyositis: a meta-analysis

    Meta-analysisMyositis

  36. Rheumatology (Oxford)

    Lymphoid interstitial pneumonia in Sjögren disease: clinical course and comparison with other ILD patterns

    Cohort studySjögren's & overlap

  37. Rheumatology (Oxford)

    The association between ethnicity, socioeconomic position and outcomes following initiation of TNF inhibitors in juvenile idiopathic arthritis: results from the UK JIA Biologics Register

    Cohort studyPediatric

  38. Rheumatology (Oxford)

    Long-term outcomes and prognosis of mixed cryoglobulinaemia: a European multicentre study of 1294 patients

    Cohort studyVasculitis & PMR

  39. Rheumatology (Oxford)

    Gastrointestinal involvement in dermatomyositis: multicentric retrospective cohort study

    Cohort studyMyositis

  40. Rheumatology (Oxford)

    Frailty in rheumatoid arthritis and the general population: a cross-sectional analysis of the Groningen Frailty Indicator and Fried criteria

    Cross-sectional studyRA

All 1,905 Briefs in ExploreShowing Briefs 121–160 of 1,905, newest first